(Q37463812)

20 August 2017

Medication usage and the risk of neoplasia in patients with Barrett's esophagus (English)

1 reference

20 August 2017

0 references

1 reference

Dang M Nguyen

1

1 reference

20 August 2017

Hashem B El-Serag

2

1 reference

20 August 2017

Louise Henderson

3

1 reference

20 August 2017

Daniel Stein

4

1 reference

20 August 2017

Achyut Bhattacharyya

5

1 reference

20 August 2017

Richard E Sampliner

6

1 reference

20 August 2017

language of work or name

English

0 references

publication date

10 June 2009

1 reference

Clinical Gastroenterology and Hepatology

20 August 2017

1 reference

20 August 2017

7

1 reference

20 August 2017

12

1 reference

20 August 2017

1299-1304

1 reference

Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Barrett's oesophagus and proton pump inhibitors: a pathological perspective

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

2 September 2018

Statins and cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Barrett's esophagus and medications that relax the lower esophageal sphincter

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

The Relation of Gastroesophageal Reflux Disease and Its Treatment to Adenocarcinomas of the Esophagus and Gastric Cardia

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789910

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

3 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19523538

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19523538

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2009.06.001

1 reference

release_apnv7qxjbvenpeirgowmj6bcu4

20 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/apnv7qxjbvenpeirgowmj6bcu4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

20 August 2017

PubMed publication ID

19523538

1 reference